文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

主动加温湿化无创通气与经鼻高流量氧疗对拔管失败极高危患者再插管影响的随机试验

Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial.
PubMed 文献 · Intensive Care Med · 2022-11-18
一句话结论拔管失败极高危(≥4项危险因素)患者拔管后48小时用主动加温湿化无创通气较经鼻高流量氧疗降低7天内再插管率(23.3% vs 38.8%)。

在西班牙两个重症监护病房开展的随机对照试验(2020年6月—2021年6月),纳入计划拔管且具备≥4项再插管危险因素的成人患者182例,随机接受拔管后48小时主动加温湿化无创通气(92例)或经鼻高流量氧疗(90例)。主要终点7天内再插管率无创通气组21例(23.3%)低于经鼻高流量氧疗组35例(38.8%),差值-15.5%(95%CI -28.3至-1%)。无创通气组医院住院时间较短(20[12-36.7]天 vs 26.5[15-45]天,差值6.5[95%CI 0.5-21.1])。其他次要终点无额外差异。作者认为对拔管失败极高危成人危重患者,主动加温湿化无创通气在预防再插管方面优于经鼻高流量氧疗。

要点

  • 纳入标准:计划拔管且具备≥4项再插管危险因素(年龄>65岁、拔管日APACHE II>12、BMI>30、分泌物管理不充分、困难或延长脱机、≥2种合并症、急性心力衰竭致机械通气、中重度COPD、气道通畅问题、延长机械通气、SBT结束时高碳酸血症)的成人患者。
  • 拔管后48小时主动加温湿化无创通气组7天内再插管21/92例(23.3%),经鼻高流量氧疗组35/90例(38.8%),差值-15.5%(95%CI -28.3至-1%)。
  • 无创通气组医院住院时间20(12-36.7)天,短于经鼻高流量氧疗组的26.5(15-45)天,差值6.5天(95%CI 0.5-21.1)。
  • 拔管后呼吸衰竭、呼吸道感染、脓毒症、多器官衰竭、死亡率、不良事件及再插管时间等其他次要终点未见额外差异。

适用人群与场景

  • 西班牙两个重症监护病房中计划拔管且具备≥4项再插管危险因素的成人危重患者。
  • 再插管危险因素包括:年龄>65岁、拔管当日急性生理与慢性健康评分II(APACHE II)>12、体重指数>30、分泌物管理不充分、困难或延长脱机、≥2种合并症、急性心力衰竭指示机械通气、中重度慢性阻塞性肺疾病、气道通畅问题、延长机械通气、自主呼吸试验结束时高碳酸血症。

诊断标准与关键阈值

  • 拔管失败极高危定义为具备≥4项上述再插管危险因素。

处置流程与药物剂量

  • 拔管后48小时内接受主动加温湿化无创通气或经鼻高流量氧疗。

研究设计与关键结果

  • 随机对照试验,西班牙两个重症监护病房,2020年6月至2021年6月,纳入182例患者(平均年龄60岁[标准差15],男性117例[64%]),主动加温湿化无创通气组92例,经鼻高流量氧疗组90例。
  • 主要终点7天内再插管率:无创通气组21例(23.3%) vs 经鼻高流量氧疗组35例(38.8%),差值-15.5%(95%CI -28.3至-1%)。
  • 医院住院时间:无创通气组20(12-36.7)天 vs 经鼻高流量氧疗组26.5(15-45)天,差值6.5天(95%CI 0.5-21.1)。
  • 其他次要终点(拔管后呼吸衰竭、呼吸道感染、脓毒症、多器官衰竭、死亡率、不良事件、再插管时间)未见额外差异。

证据类型、等级与局限

  • 随机对照试验;局限:原文未报告局限性。

对床旁实践的改变

  • 对计划拔管且具备≥4项再插管危险因素的成人危重患者,拔管后48小时使用主动加温湿化无创通气较经鼻高流量氧疗可降低7天内再插管率(23.3% vs 38.8%)。
  • 该人群使用主动加温湿化无创通气与医院住院时间缩短相关(20[12-36.7]天 vs 26.5[15-45]天)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: High-flow nasal cannula (HFNC) oxygen therapy was noninferior to noninvasive ventilation (NIV) for preventing reintubation in a heterogeneous population at high-risk for extubation failure. However, outcomes might differ in certain subgroups of patients. Thus, we aimed to determine whether NIV with active humidification is superior to HFNC in preventing reintubation in patients with ≥ 4 risk factors (very high risk for extubation failure).

METHODS: Randomized controlled trial in two intensive care units in Spain (June 2020‒June 2021). Patients ready for planned extubation with ≥ 4 of the following risk factors for reintubation were included: age > 65 years, Acute Physiology and Chronic Health Evaluation II score > 12 on extubation day, body mass index > 30, inadequate secretions management, difficult or prolonged weaning, ≥ 2 comorbidities, acute heart failure indicating mechanical ventilation, moderate-to-severe chronic obstructive pulmonary disease, airway patency problems, prolonged mechanical ventilation, or hypercapnia on finishing the spontaneous breathing trial. Patients were randomized to undergo NIV with active humidification or HFNC for 48 h after extubation. The primary outcome was reintubation rate within 7 days after extubation. Secondary outcomes included postextubation respiratory failure, respiratory infection, sepsis, multiorgan failure, length of stay, mortality, adverse events, and time to reintubation.

RESULTS: Of 182 patients (mean age, 60 [standard deviation (SD), 15] years; 117 [64%] men), 92 received NIV and 90 HFNC. Reintubation was required in 21 (23.3%) patients receiving NIV vs 35 (38.8%) of those receiving HFNC (difference -15.5%; 95% confidence interval (CI) -28.3 to -1%). Hospital length of stay was lower in those patients treated with NIV (20 [12‒36.7] days vs 26.5 [15‒45] days, difference 6.5 [95%CI 0.5-21.1]). No additional differences in the other secondary outcomes were observed.

CONCLUSIONS: Among adult critically ill patients at very high-risk for extubation failure, NIV with active humidification was superior to HFNC for preventing reintubation.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hernández G, Paredes I, Moran F, et al. Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial. Intensive Care Med. 2022. PMID: 36400984. doi:10.1007/s00134-022-06919-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。